Medipower M Stock Fundamentals
| MDPR Stock | ILS 654.40 14.40 2.25% |
As of the 28th of January, Medipower secures the Risk Adjusted Performance of (0.01), standard deviation of 2.28, and Mean Deviation of 1.74. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medipower M, as well as the relationship between them.
Medipower's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Medipower's valuation are provided below:Medipower M does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Medipower |
Medipower 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medipower's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medipower.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Medipower on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Medipower M or generate 0.0% return on investment in Medipower over 90 days. Medipower is related to or competes with Netanel, Polygon L, Maslavi, Av Gad, Mishorim Real, Aspen, and Ravad. Limited owns and manages retail properties and residential developments in the United States, Canada, and Bulgaria More
Medipower Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medipower's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medipower M upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 10.6 | |||
| Value At Risk | (3.84) | |||
| Potential Upside | 3.58 |
Medipower Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medipower's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medipower's standard deviation. In reality, there are many statistical measures that can use Medipower historical prices to predict the future Medipower's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | 2.08 |
Medipower January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 2.09 | |||
| Mean Deviation | 1.74 | |||
| Coefficient Of Variation | (4,668) | |||
| Standard Deviation | 2.28 | |||
| Variance | 5.21 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | 2.08 | |||
| Maximum Drawdown | 10.6 | |||
| Value At Risk | (3.84) | |||
| Potential Upside | 3.58 | |||
| Skewness | 0.1075 | |||
| Kurtosis | (0.1) |
Medipower M Backtested Returns
Medipower M has Sharpe Ratio of -0.0366, which conveys that the firm had a -0.0366 % return per unit of risk over the last 3 months. Medipower exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medipower's Standard Deviation of 2.28, mean deviation of 1.74, and Risk Adjusted Performance of (0.01) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.0283, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medipower are expected to decrease at a much lower rate. During the bear market, Medipower is likely to outperform the market. At this point, Medipower M has a negative expected return of -0.0741%. Please make sure to verify Medipower's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Medipower M performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.16 |
Insignificant reverse predictability
Medipower M has insignificant reverse predictability. Overlapping area represents the amount of predictability between Medipower time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medipower M price movement. The serial correlation of -0.16 indicates that over 16.0% of current Medipower price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.16 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 184.23 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medipower M has a Return On Asset of 0.0343. This is 92.7% lower than that of the Real Estate Management & Development sector and 100.85% lower than that of the Real Estate industry. The return on asset for all Israel stocks is 124.5% lower than that of the firm.
Medipower M Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medipower's current stock value. Our valuation model uses many indicators to compare Medipower value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medipower competition to find correlations between indicators driving Medipower's intrinsic value. More Info.Medipower M is regarded second in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about 0.25 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medipower M is roughly 3.97 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medipower by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medipower's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Medipower Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medipower's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medipower could also be used in its relative valuation, which is a method of valuing Medipower by comparing valuation metrics of similar companies.Medipower is currently under evaluation in return on asset category among its peers.
Medipower Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.32 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 386.99 M | |||
| Shares Outstanding | 51.14 M | |||
| Shares Owned By Insiders | 53.26 % | |||
| Shares Owned By Institutions | 31.80 % | |||
| Price To Sales | 7.91 X | |||
| Revenue | 37.23 M | |||
| Gross Profit | 21.16 M | |||
| EBITDA | 11.35 M | |||
| Net Income | 9.19 M | |||
| Cash And Equivalents | 7.58 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 108.11 M | |||
| Debt To Equity | 141.30 % | |||
| Current Ratio | 1.39 X | |||
| Book Value Per Share | 2.29 X | |||
| Cash Flow From Operations | 9.5 M | |||
| Earnings Per Share | 0.12 X | |||
| Beta | 0.45 | |||
| Market Capitalization | 298.74 M | |||
| Total Asset | 100 M | |||
| Retained Earnings | 10 M | |||
| Working Capital | (15 M) | |||
| Current Asset | 7 M | |||
| Current Liabilities | 22 M | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.03 % |
About Medipower Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medipower M's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medipower using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medipower M based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Limited owns and manages retail properties and residential developments in the United States, Canada, and Bulgaria. The company was incorporated in 2001 and is based in Nicosia, Cyprus. MEDIPOWER OVERSEAS is traded on Tel Aviv Stock Exchange in Israel.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HITI | High Tide | |
| HITI | High Tide | |
| BAC | Bank of America |
Other Information on Investing in Medipower Stock
Medipower financial ratios help investors to determine whether Medipower Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipower with respect to the benefits of owning Medipower security.